Skip to content

Lipoabdominoplasty and Diaphragmatic Mobility

Repercussions of Lipoabdominoplasty Surgery on Diaphragmatic Mobility, Regional Distribution Ventilation of Thoracoabdominal System and Lung Function in Women Healthy.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02762526
Enrollment
15
Registered
2016-05-05
Start date
2016-05-31
Completion date
2016-05-31
Last updated
2016-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominoplasty Surgery

Keywords

lipectomy, abdominoplasty, plethysmography optoelectronics, diaphragmatic mobility, lung function, respiratory muscles

Brief summary

Background: The lipoabdominoplasty can lead to respiratory complications in the postoperative period becoming critical early clinical and functional evaluation of respiratory muscles, seeking to direct a more effective treatment, which can result in shorter hospital stays and lower spending on health in patients undergoing such procedures. Objective: To evaluate the correlation of regional distribution of ventilation system with thoracoabdominal diaphragmatic mobility in women undergoing surgery lipoabdominoplasty comparing preoperative, 10 ° and 30 ° DPO DPO. Methods: This is a prospective cohort study, which will be evaluated 30 women aged 25 to 55 years undergoing lipoabdominoplasty surgery without respiratory or prior cardiac comorbidities and body mass index (BMI) ≤ 30 kg / cm2. women smokers are deleted and / or a history of smoking more than 10 years and unable to understand the commands to perform the proposed methods. For evaluation of diaphragmatic mobility will be used high-resolution ultrasound with convex 3.5 MHz transducer. The evaluation of the regional distribution of ventilation thoracoabdominal system will be made using the optoelectronic plethysmograph (POE). The strength of the inspiratory and expiratory muscles is measured through a digital manometer connected to a nozzle with an orifice of 2 mm to reduce the closing pressure of the glottis. A portable spirometer is used for assessment of pulmonary function and evaluation of dyspnea will be used modified Borg scale. The data will be evaluated in the preoperative period, 10 days and 30 days postoperatively. Hypotheses: Patients undergoing surgery lipoabdominoplasty have decreased diaphragmatic mobility, strength and respiratory function, in addition to presenting changes in the pattern of regional ventilation distribution in torocoabdominal system in the postoperative period when compared to the preconditions surgery.

Detailed description

Introduction: The lipoabdominoplasty can lead to respiratory complications in the postoperative period becoming critical early clinical and functional evaluation of respiratory muscles, seeking to direct a more effective treatment, which can result in shorter hospital stays and lower spending on health in patients subjected to this type of procedure. hypotheses: Patients undergoing lipoabdominoplasty surgery with muscular plication, have decreased diaphragmatic mobility, strength and respiratory function, in addition to presenting changes in the regional distribution pattern of ventilation in torocoabdominal system in the postoperative period when compared to the preconditions surgery . Goal: To evaluate the correlation of regional distribution of ventilation system with thoracoabdominal diaphragmatic mobility in women undergoing surgery lipoabdominoplasty comparing preoperative, 10 ° and 30 ° DPO DPO. Hypothesis: Patients undergoing surgery lipoabdominoplasty have decreased diaphragmatic mobility, strength and respiratory function, in addition to presenting changes in the pattern of regional ventilation distribution in torocoabdominal system in the postoperative period when compared to the preconditions surgery. Materials and methods: This is a prospective cohort study, which will be evaluated 30 women between 30 and 50 years underwent surgery lipoabdominoplasty without respiratory or prior cardiac comorbidities and body mass index (BMI) ≤ 30 kg / cm2. women smokers are deleted and / or a history of smoking greater than 10 years, FEV1 \<80% predicted, FEV1 / FVC \<70% of predicted and unable to understand the commands to perform the proposed methods. For evaluation of diaphragmatic mobility and thickness will be used high-resolution ultrasound with a convex transducer of 3.5 MHz and 7.5 MHz linear transducer, respectively. The assessment of the regional distribution of ventilation thoracoabdominal system will be made using the optoelectronic plethysmograph (POE). The strength of the inspiratory and expiratory muscles is measured through a digital manometer connected to a nozzle with an orifice of 2 mm to reduce the closing pressure of the glottis. A portable spirometer is used for assessment of pulmonary function and evaluation of dyspnea will be used modified Borg scale. The data will be evaluated in the preoperative period, 10 days and 30 days postoperatively.

Interventions

Sponsors

Universidade Federal de Pernambuco
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* women will be included between 25 and 55 years underwent surgery lipoabdominoplasty without respiratory or prior cardiac comorbidities and body mass index (BMI) ≤ 30 kg / cm2.

Exclusion criteria

* women smokers will be deleted and / or a history of smoking more than 10 years; FEV1 \<80% predicted and FEV1 / FVC \<70% of predicted; unable to understand the commands to perform the proposed methods.

Design outcomes

Primary

MeasureTime frameDescription
Mobility Diaphragmatic30 daysMeasure diaphragmatic mobility for total lung capacity maneuver
plethysmography optoelectronics30 daysmeasuring the change in lung volumes in the three compartments

Contacts

Primary ContactSandra Fluhr, Specialist
sandrafluhr@hotmail.com+55 81 999222441
Backup ContactDaniella Brandão, PHD
daniellacunha@hotmail.com+55 81 2126-8496

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026